HEMI owners are modding their vehicles to remove a particular built-in feature, but does it actually help and what are the ...

According to results from the IMerge trial, 2 39.8% of patients treated with imetelstat achieved 8 weeks of transfusion ...

Myelodysplastic syndromes (MDS) are a group of blood cancers that affect the bone marrow and can result in a low levels of blood cells. When MDS affects red blood cells, it can lead to anemia in some ...

Myelodysplastic syndromes (MDS) cause atypical bone marrow cells and low blood counts. This can lead to fatigue, shortness of breath, infections, bruising, and bleeding. Myelodysplastic syndromes (MDS ...

Patients with MDS report more symptoms than physicians, indicating a communication gap in symptom assessment. Allogeneic hematopoietic stem cell transplantation is the only cure but is limited to ...

The FDA approved Geron's Rytelo for specific low-risk MDS patients, a significant milestone for the company. Rytelo faces stiff competition in the MDS market, particularly from drugs like Reblozyl, ...

Geron is planning to submit a New Drug Application (NDA) for imetelstat, a treatment for low to intermediate-1 risk myelodysplastic syndromes (MDS), in 2023 after favorable Phase 3 trial results.

I own a 2014 Ford F-150 Platinum. I purchased it used a few years ago with 88,000 original miles on the odometer. I love this truck. We named her Ruby for ...

Skilled nursing providers bracing for yet another audit process should prepare for medical record requests sooner rather than later, especially if the federal government shutdown ends this week as ...